LogicMark, Inc. - Quarter Report: 2023 March (Form 10-Q)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
(Mark One)
☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended March 31, 2023
or
☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from to
Commission File Number: 001-36616
LogicMark, Inc.
(Exact name of registrant as specified in its charter)
Delaware | 46-0678374 | |
(State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification No.) |
2801 Diode Lane |
Louisville, KY 40299 |
(Address of principal executive offices) (Zip Code)
|
(502) 442-7911 |
(Registrant’s telephone number, including area code) |
Securities registered pursuant to Section 12(b) of the Act
Title of each class | Trading Symbol(s) | Name of exchange on which registered | ||
Common Stock, par value $0.0001 per share | LGMK | Nasdaq Capital Market |
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or such shorter period that the registrant was required to submit such files). Yes ☒ No ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer | ☐ | Accelerated filer | ☐ |
Non-accelerated filer | ☒ | Smaller reporting company | ☒ |
Emerging growth company | ☐ |
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒
As of May 10, 2023, there were 1,287,518 shares of common stock, par value $0.0001 per share, of the registrant issued and outstanding.
LogicMark, Inc.
Form 10-Q
Table of Contents
March 31, 2023
i
PART I. FINANCIAL INFORMATION
Item 1. Condensed Financial Statements (Unaudited)
LogicMark, Inc.
CONDENSED BALANCE SHEETS
(Unaudited)
March 31, | December 31, | |||||||
2023 | 2022 | |||||||
Assets | ||||||||
Current Assets | ||||||||
Cash and cash equivalents | $ | 9,781,799 | $ | 6,977,114 | ||||
Restricted cash | 59,988 | 59,988 | ||||||
Accounts receivable, net | 50,679 | 402,595 | ||||||
Inventory | 1,134,497 | 1,745,211 | ||||||
Prepaid expenses and other current assets | 292,319 | 349,097 | ||||||
Total Current Assets | 11,319,282 | 9,534,005 | ||||||
Property and equipment, net | 252,855 | 255,578 | ||||||
Right-of-use assets, net | 164,554 | 182,363 | ||||||
Product development costs, net of amortization of $15,029 | 1,253,749 | 1,010,662 | ||||||
Goodwill | 10,958,662 | 10,958,662 | ||||||
Other intangible assets, net of amortization of $4,900,886 and $4,710,437, respectively | 3,509,405 | 3,699,854 | ||||||
Total Assets | $ | 27,458,507 | $ | 25,641,124 | ||||
Liabilities, Series C Redeemable Preferred Stock and Stockholders’ Equity | ||||||||
Current Liabilities | ||||||||
Accounts payable | $ | 521,283 | $ | 673,052 | ||||
Accrued expenses | 750,532 | 1,740,490 | ||||||
Total Current Liabilities | 1,271,815 | 2,413,542 | ||||||
Other long-term liabilities | 424,195 | 440,263 | ||||||
Total Liabilities | 1,696,010 | 2,853,805 | ||||||
Commitments and Contingencies (Note 8) | ||||||||
Series C Redeemable Preferred Stock | ||||||||
Series C redeemable preferred stock, par value $0.0001 per share: 2,000 shares designated; 10 shares issued and outstanding as of March 31, 2023 and December 31, 2022 | 1,807,300 | 1,807,300 | ||||||
Stockholders’ Equity | ||||||||
Preferred stock, par value $0.0001 per share: 10,000,000 shares authorized | ||||||||
Series F preferred stock, par value $0.0001 per share: 1,333,333 shares designated; 106,333 and 173,333 shares issued and outstanding as of March 31, 2023 and December 31, 2022, respectively, aggregate liquidation preference of $319,000 as of March 31, 2023 and $520,000 as of December 31, 2022 | 319,000 | 520,000 | ||||||
Common stock, par value $0.0001 per share: 100,000,000 shares authorized; 1,220,308 and 479,669 issued and outstanding as of March 31, 2023 and December 31, 2022, respectively | 123 | 48 | ||||||
Additional paid-in capital | 111,079,795 | 106,070,253 | ||||||
Accumulated deficit | (87,443,721 | ) | (85,610,282 | ) | ||||
Total Stockholders’ Equity | 23,955,197 | 20,980,019 | ||||||
Total Liabilities, Series C Redeemable Preferred Stock and Stockholders’ Equity | $ | 27,458,507 | $ | 25,641,124 |
The accompanying notes are an integral part of these condensed financial statements.
1
LogicMark, Inc.
CONDENSED STATEMENTS OF OPERATIONS
(Unaudited)
For the Three Months Ended March 31, | ||||||||
2023 | 2022 | |||||||
Revenues | $ | 2,809,717 | $ | 3,650,689 | ||||
Costs of goods sold | 947,169 | 1,447,305 | ||||||
Gross Profit | 1,862,548 | 2,203,384 | ||||||
Operating Expenses | ||||||||
Direct operating cost | 262,800 | 474,442 | ||||||
Advertising costs | 48,116 | |||||||
Selling and marketing | 465,536 | 189,207 | ||||||
Research and development | 313,887 | 262,484 | ||||||
General and administrative | 2,413,760 | 2,335,949 | ||||||
Other expense | 28,318 | 30,084 | ||||||
Depreciation and amortization | 215,998 | 194,363 | ||||||
Total Operating Expenses | 3,748,415 | 3,486,529 | ||||||
Operating Loss | (1,885,867 | ) | (1,283,145 | ) | ||||
Other Income | ||||||||
Interest income | 52,428 | |||||||
Total Other Income | 52,428 | |||||||
Loss before Income Taxes | (1,833,439 | ) | (1,283,145 | ) | ||||
Income tax expense | ||||||||
Net Loss | (1,833,439 | ) | (1,283,145 | ) | ||||
Preferred stock dividends | (75,000 | ) | (88,000 | ) | ||||
Net Loss Attributable to Common Stockholders | $ | (1,908,439 | ) | $ | (1,371,145 | ) | ||
$ | (1.92 | ) | $ | (2.89 | ) | |||
996,080 | 474,099 |
The accompanying notes are an integral part of these condensed financial statements.
2
LogicMark, Inc.
CONDENSED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY
(Unaudited)
Three Months Ended March 31, 2023 | ||||||||||||||||||||||||||||
Additional | ||||||||||||||||||||||||||||
Preferred Stock | Common Stock | Paid-in | Accumulated | |||||||||||||||||||||||||
Shares | Amount | Shares | Amount | Capital | Deficit | Total | ||||||||||||||||||||||
Balance - January 1, 2023 | 173,333 | $ | 520,000 | 480,447 | $ | 48 | $ | 106,070,253 | $ | (85,610,282 | ) | $ | 20,980,019 | |||||||||||||||
Stock-based compensation expense | 426,842 | 426,842 | ||||||||||||||||||||||||||
Shares issued as stock compensation | 5,000 | 1 | 2,202 | 2,203 | ||||||||||||||||||||||||
Sale of common stock and warrants pursuant to a registration statement on Form S-1 | 701,250 | 70 | 5,211,358 | 5,211,428 | ||||||||||||||||||||||||
Fees incurred in connection with equity offerings | (805,245 | ) | (805,245 | ) | ||||||||||||||||||||||||
Series F Preferred stock converted to common stock | (67,000 | ) | (201,000 | ) | 27,089 | 3 | 200,997 | |||||||||||||||||||||
Common stock issued to settle Series F Preferred stock dividends | 6,522 | 1 | 48,388 | 48,389 | ||||||||||||||||||||||||
Series C Preferred stock dividends | (75,000 | ) | (75,000 | ) | ||||||||||||||||||||||||
Net loss | - | - | (1,833,439 | ) | (1,833,439 | ) | ||||||||||||||||||||||
Balance - March 31, 2023 | 106,333 | $ | 319,000 | 1,220,308 | $ | 123 | $ | 111,079,795 | $ | (87,443,721 | ) | $ | 23,955,197 |
Three Months Ended March 31, 2022 | ||||||||||||||||||||||||||||
Additional | ||||||||||||||||||||||||||||
Preferred Stock | Common Stock | Paid-in | Accumulated | |||||||||||||||||||||||||
Shares | Amount | Shares | Amount | Capital | Deficit | Total | ||||||||||||||||||||||
Balance - January 1, 2022 | 173,333 | $ | 520,000 | 458,152 | $ | 46 | $ | 104,725,986 | $ | (78,656,861 | ) | $ | 26,589,171 | |||||||||||||||
Stock-based compensation expense | 512,349 | 512,349 | ||||||||||||||||||||||||||
Shares issued as stock compensation | 21,517 | 2 | 117,451 | 117,453 | ||||||||||||||||||||||||
Series C Preferred stock dividends | (75,000 | ) | (75,000 | ) | ||||||||||||||||||||||||
Series F Preferred stock dividends | (13,000 | ) | (13,000 | ) | ||||||||||||||||||||||||
Net loss | - | - | (1,283,145 | ) | (1,283,145 | ) | ||||||||||||||||||||||
Balance - March 31, 2022 | 173,333 | $ | 520,000 | 479,669 | $ | 48 | $ | 105,280,786 | $ | (79,953,006 | ) | $ | 25,847,828 |
The accompanying notes are an integral part of these condensed financial statements.
3
LogicMark, Inc.
CONDENSED STATEMENTS OF CASH FLOWS
(Unaudited)
For the Three Months Ended March 31, | ||||||||
2023 | 2022 | |||||||
Cash Flows from Operating Activities | ||||||||
Net loss | $ | (1,833,439 | ) | $ | (1,283,145 | ) | ||
Adjustments to reconcile net loss to net cash (used in) provided by operating activities: | ||||||||
Depreciation | 25,549 | 257 | ||||||
Stock based compensation | 429,045 | 629,802 | ||||||
Amortization of intangible assets | 190,449 | 194,106 | ||||||
Changes in operating assets and liabilities: | ||||||||
Accounts receivable | 351,916 | (34,513 | ) | |||||
Inventory | 610,714 | 361,196 | ||||||
Prepaid expenses and other current assets | 56,778 | (44,198 | ) | |||||
Accounts payable | (229,741 | ) | 566,983 | |||||
Accrued expenses | (984,157 | ) | (98,041 | ) | ||||
Net Cash (Used in) Provided by Operating Activities | (1,382,886 | ) | 292,447 | |||||
Cash flows from Investing Activities | ||||||||
Purchase of equipment and website development | (5,732 | ) | (36,988 | ) | ||||
Product development costs | (137,880 | ) | ||||||
Net Cash Used in Investing Activities | (143,612 | ) | (36,988 | ) | ||||
Cash flows from Financing Activities | ||||||||
Proceeds from sale of common stock and warrants | 5,211,428 | |||||||
Fees paid in connection with equity offerings | (805,245 | ) | ||||||
Series C redeemable preferred stock dividends | (75,000 | ) | (75,000 | ) | ||||
Net Cash Provided by (Used in) Financing Activities | 4,331,183 | (75,000 | ) | |||||
Net Increase in Cash, Cash Equivalents and Restricted Cash | 2,804,685 | 180,459 | ||||||
Cash, Cash Equivalents and Restricted Cash - Beginning of Period | 7,037,102 | 12,254,546 | ||||||
Cash, Cash Equivalents and Restricted Cash - End of Period | $ | 9,841,787 | $ | 12,435,005 | ||||
Supplemental Disclosures of Cash Flow Information: | ||||||||
Non-cash investing and financing activities: | ||||||||
Accrued Series C redeemable and Series F preferred stock dividends | $ | $ | 107,933 | |||||
Conversion of Series F preferred stock to common stock | 201,000 | |||||||
Common stock issued to settle Series F Preferred stock dividends | 48,389 | |||||||
Equipment purchases and website development included in accounts payable and accrued expenses | 17,094 | |||||||
Product development costs included in accounts payable and accrued expenses | 105,207 |
The accompanying notes are an integral part of these condensed financial statements.
4
LogicMark, Inc.
NOTES TO CONDENSED FINANCIAL STATEMENTS
(Unaudited)
NOTE 1 - ORGANIZATION AND PRINCIPAL BUSINESS ACTIVITIES
LogicMark, Inc. (“LogicMark” or the “Company”) was incorporated in the State of Delaware on February 8, 2012. LogicMark operates its business in one segment and provides personal emergency response systems (PERS), health communications devices, and Internet of Things technology that creates a connected care platform. The Company’s devices give people the ability to receive care at home and confidence to age independently. LogicMark revolutionized the PERS industry by incorporating two-way voice communication technology directly in the medical alert pendant and providing life-saving technology at a price point everyday consumers could afford. The PERS technologies are sold through retailers and distributors, as well as to the United States Veterans Health Administration.
The Company manufactures and distributes non-monitored and monitored personal emergency response systems sold through the United States Veterans Health Administration, healthcare durable medical equipment retailers and distributors and monitored security retailers and distributors. In 2022, the Company launched an e-commerce website to sell direct to consumers.
NOTE 2 - LIQUIDITY AND MANAGEMENT PLANS
The Company generated an operating loss of $1.9 million and a net loss of $1.8 million for the three months ended March 31, 2023. As of March 31, 2023, the Company had cash and cash equivalents of $9.8 million. As of March 31, 2023, the Company had working capital of $10.0 million compared to working capital as of December 31, 2022 of $7.1 million.
Given the Company’s cash position at March 31, 2023, and its projected cash flow from operations, the Company believes that it will have sufficient capital to sustain operations for a period of one year following the date of this filing. The Company may also raise funds through equity or debt offerings to accelerate the execution of its long-term strategic plan to develop and commercialize its core products and to fulfill its product development commitments.
NOTE 3 - BASIS OF PRESENTATION
The accompanying unaudited condensed financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“U.S. GAAP”) and applicable rules and regulations of the Securities and Exchange Commission (“SEC”) regarding interim financial reporting. In the opinion of management, the information herein reflects all adjustments, consisting only of normal recurring adjustments except as otherwise noted, considered necessary for a fair statement of results of operations, financial position, stockholders’ equity, and cash flows. The results for the interim periods presented are not necessarily indicative of the results expected for any future period. The following information should be read in conjunction with the audited financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2022 which was filed with the SEC on March 30, 2023.
Net loss per share and all share data for the three months ended March 31, 2023 and 2022 have been retroactively adjusted to reflect the 1-for-20 reverse stock split that occurred in April 2023, in accordance with ASC 260-10-55-22, Restatement of EPS Data. See Note 9.
Certain prior year amounts have been reclassified for consistency with the current year’s presentation. These reclassifications had no effect on the reported results of operations.
NOTE 4 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
USE OF ESTIMATES IN THE CONDENSED FINANCIAL STATEMENTS
U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed financial statements and the reported amounts of revenues and expenses during the reporting period. The Company’s management evaluates these significant estimates and assumptions, including those related to the fair value of acquired assets and liabilities, stock-based compensation, income taxes, allowance for doubtful accounts, long-lived assets, and inventories, and other matters that affect the condensed financial statements and disclosures. Actual results could differ from those estimates.
CASH AND CASH EQUIVALENTS
The Company considers all highly liquid securities with an original maturity date of three months or less when purchased to be cash equivalents. Due to their short-term nature, cash equivalents are carried at cost, which approximates fair value. The Company had cash equivalents of $9.2 million and $6.6 million as of March 31, 2023 and December 31, 2022, respectively.
5
LogicMark, Inc.
NOTES TO CONDENSED FINANCIAL STATEMENTS
(Unaudited)
NOTE 4 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)
RESTRICTED CASH
Restricted cash includes amounts held as collateral for company credit cards. Restricted cash included in Cash, Cash Equivalents and Restricted Cash, as presented on the Condensed Statements of Cash Flows amounted to $60 thousand as of March 31, 2023 and December 31, 2022.
CONCENTRATIONS OF CREDIT RISK
Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash and cash equivalents. The Company maintains its cash and cash equivalents balances in large well-established financial institutions located in the United States. At times, the Company’s cash balances may be uninsured or in deposit accounts that exceed the Federal Deposit Insurance Corporation (“FDIC”) insurance limits.
REVENUE RECOGNITION
The Company’s revenues consist of product sales to either end customers, to distributors or bulk sales to the United States Veterans Health Administration. The Company’s revenues are derived from contracts with customers, which are in most cases customer purchase orders. For each contract, the promise to transfer the control of the products, each of which is individually distinct, is considered to be the identified performance obligation. As part of the consideration promised in each contract, the Company evaluates the customer’s credit risk. Our contracts do not have any financing components, as payments are generally prepaid or due Net 30 days after the invoice date for retailers and distributors. The Company’s products are almost always sold at fixed prices. In determining the transaction price, we evaluate whether the price is subject to any refunds, due to product returns or adjustments due to volume discounts, rebates, or price concessions to determine the net consideration we expect to be entitled to. The Company’s sales are recognized at a point-in-time under the core principle of recognizing revenue when control transfers to the customer, which generally occurs when the Company ships or delivers the product from its fulfillment center to our customers, when our customer accepts and has legal title of the goods, and the Company has a present right to payment for such goods. Based on the respective contract terms, most of our contract revenues are recognized either (i) upon shipment based on free on board (“FOB”) shipping point, or (ii) when the product arrives at its destination. For the three months ended March 31, 2023 and 2022, none of our sales were recognized over time.
SALES TO DISTRIBUTORS AND RETAILERS
The Company maintains a reserve for unprocessed and estimated future price adjustments claims and returns as a refund liability. The reserve is recorded as a reduction to revenue in the same period that the related revenue is recorded and is calculated based on an analysis of historical claims and returns over a period of time to appropriately account for current pricing and business trends. Similarly, sales returns and allowances are recorded based on historical return rates, as a reduction to revenue with a corresponding reduction to cost of goods sold for the estimated cost of inventory that is expected to be returned. These reserves were not material as of March 31, 2023 and December 31, 2022.
SHIPPING AND HANDLING
Amounts billed to customers for shipping and handling are included in revenues. The related freight charges incurred by the Company are included in cost of goods sold and were $0.1 million and $0.2 million, respectively, for the three months ended March 31, 2023 and 2022.
6
LogicMark, Inc.
NOTES TO CONDENSED FINANCIAL STATEMENTS
(Unaudited)
NOTE 4 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)
ACCOUNTS RECEIVABLE - NET
For the three months ended March 31, 2023 and 2022, the Company’s revenues were primarily the result of shipments to VA hospitals and clinics, which are made on a prepaid basis. The Company also sells its products to distributors and retailers, typically providing customers with trade credit terms. Sales made to distributors and retailers are done with limited rights of return and are subject to the normal warranties offered to the ultimate consumer for product defects.
Accounts receivable is stated at net realizable value. The Company regularly reviews accounts receivable balances and adjusts the accounts receivable allowance for doubtful accounts, as necessary whenever events or circumstances indicate the carrying value may not be recoverable. As of March 31, 2023 and December 31, 2022, the allowance for doubtful accounts were immaterial.
INVENTORY
The Company measures inventory at the lower of cost or net realizable value, defined as estimated selling prices in the ordinary course of business, less reasonably predictable costs of completion, disposal, and transportation. Cost is determined using the first-in, first-out method.
The Company performs regular reviews of inventory quantities on hand and evaluates the realizable value of its inventories. The Company adjusts the carrying value of the inventory as necessary for excess, obsolete, and slow-moving inventory by comparing the individual inventory parts to forecasted product demand or production requirements. As of March 31, 2023, inventory was comprised of $1.1 million and $60 thousand, in finished goods on hand and inventory in-transit from vendors, respectively. As of December 31, 2022, inventory was comprised of $0.6 million and $1.2 million, in finished goods on hand and inventory in-transit from vendors, respectively.
The Company is required to prepay for inventory with certain vendors until credit terms can be established. As of March 31, 2023, the Company did not have prepaid inventory and as of December 31, 2022, $0.01 million of prepayments made for inventory are included in prepaid expenses and other current assets on the balance sheet.
LONG-LIVED ASSETS
Long-lived assets, such as property and equipment, and other intangibles are evaluated for impairment whenever events or changes in circumstances indicate the carrying value of an asset may not be recoverable. When indicators exist, the Company tests for the impairment of the definite-lived assets based on the undiscounted future cash flow the assets are expected to generate over their remaining useful lives, compared to the carrying value of the assets. If the carrying amount of the assets is determined not to be recoverable, a write-down to fair value is recorded. Management estimates future cash flows using assumptions about expected future operating performance. Management’s estimates of future cash flows may differ from actual cash flow due to, among other things, technological changes, economic conditions, or changes to the Company’s business operations.
PROPERTY AND EQUIPMENT
Property and equipment consisting of equipment, furniture, fixtures, website and other is stated at cost. The costs of additions and improvements are generally capitalized and expenditures for repairs and maintenance are expensed in the period incurred. When items of property and equipment are sold or retired, the related costs and accumulated depreciation are removed from the accounts and any gain or loss is included in income. Depreciation of property and equipment is provided utilizing the straight-line method over the estimated useful life of the respective asset as follows:
Equipment | 5 years | |
Furniture and fixtures | 3 to 5 years | |
Website and other | 3 years |
7
LogicMark, Inc.
NOTES TO CONDENSED FINANCIAL STATEMENTS
(Unaudited)
NOTE 4 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)
GOODWILL
Goodwill is reviewed annually in the fourth quarter, or when circumstances indicate that an impairment may have occurred. The Company first performs a qualitative assessment of goodwill impairment, which considers factors such as market conditions, performance compared to forecast, business outlook and unusual events. If the qualitative assessment indicates a possible goodwill impairment, goodwill is then quantitatively tested for impairment. The Company may elect to bypass the qualitative assessment and proceed directly to the quantitative test. If a quantitative goodwill impairment test is required, the fair value is determined using a variety of assumptions including estimated future cash flows using applicable discount rates (income approach) and comparisons to other similar companies (market approach).
OTHER INTANGIBLE ASSETS
The Company’s intangible assets are related to the acquisition of LogicMark LLC in 2016, the former subsidiary that was merged with and into the Company and are included in other intangible assets in the Company’s Condensed Balance Sheets as of March 31, 2023 and December 31, 2022.
As of March 31, 2023, the other intangible assets are comprised of patents of $1.6 million; trademarks of $0.8 million; and customer relationships of $1.1 million. As of December 31, 2022, the other intangible assets are comprised of patents of $1.7 million; trademarks of $0.9 million; and customer relationships of $1.2 million. The Company amortizes these intangible assets using the straight-line method over their estimated useful lives which for the patents, trademarks and customer relationships are 11 years, 20 years, and 10 years, respectively. During the three months ended March 31, 2023 and 2022, the Company had amortization expense of $0.2 million, respectively.
As of March 31, 2023, total amortization expense estimated for the remainder of fiscal year 2023 is $0.6 million. Amortization expense estimated for
and is expected to be approximately $0.8 million per year, $0.6 million for , $0.3 million for , and approximately $63 thousand each year until fully amortized in 2036.
8
LogicMark, Inc.
NOTES TO CONDENSED FINANCIAL STATEMENTS
(Unaudited)
NOTE 4 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)
STOCK-BASED COMPENSATION
The Company accounts for share-based awards exchanged for employee services at the estimated grant date fair value of the award. The Company accounts for equity instruments issued to non-employees at their fair value on the measurement date. The measurement of stock-based compensation is subject to periodic adjustment as the underlying equity instrument vests or becomes non-forfeitable. Stock-based compensation charges are amortized over the vesting period or as earned. Stock-based compensation is recorded in the same component of operating expenses as if it were paid in cash.
NET LOSS ATTRIBUTABLE TO COMMON STOCKHOLDERS PER SHARE
Basic net loss attributable to common stockholders per share (“Basic net loss per share”) was computed using the weighted average number of common shares outstanding. Diluted net loss applicable to common stockholders per share (“Diluted net loss per share”) includes the effect of diluted common stock equivalents. Potentially dilutive securities from the exercise of stock options to purchase 36,053 shares of common stock and warrants to purchase 1,327,784 shares of common stock as of March 31, 2023, were excluded from the computation of diluted net loss per share because the effect of their inclusion would have been anti-dilutive. Potentially dilutive securities from the exercise of stock options to purchase 17,434 shares of common stock and warrants to purchase 214,770 shares of common stock as of March 31, 2022, were excluded from the computation of diluted net loss per share because the effect of their inclusion would have been anti-dilutive.
RESEARCH AND DEVELOPMENT AND PRODUCT DEVELOPMENT COSTS
Research and development costs are expenditures on new market development and related engineering costs. In addition to internal resources, the Company utilizes functional consulting resources, third-party software, and hardware development firms. The Company expenses all research and development costs as incurred until technological feasibility has been established for the product. Once technological feasibility is established, development costs including software and hardware design are capitalized until the product is available for general release to customers. Judgment is required in determining when technological feasibility of a product is established. For the three months ended March 31, 2023, the Company capitalized $0.2 million of such product development costs. There was no amortization of product development costs during the three months ended March 31, 2023. No product development costs were capitalized or amortized during the three months ended March 31, 2022. Cumulatively, as of March 31, 2023 and December 31, 2022, approximately $0.4 million and $0.3 million, respectively, of capitalized product development costs arose from expenditures to a company considered to be a related party since it is controlled by the Company’s Vice-President of Engineering.
9
LogicMark, Inc.
NOTES TO CONDENSED FINANCIAL STATEMENTS
(Unaudited)
NOTE 4 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)
RECENT ACCOUNTING PRONOUNCEMENTS
Recent accounting standards that have been issued or proposed by FASB or other standards-setting bodies that do not require adoption until a future date are not expected to have a material impact on the Company’s condensed financial statements upon adoption.
NOTE 5 - ACCRUED EXPENSES
Accrued expenses consist of the following:
March 31, | December 31, | |||||||
2023 | 2022 | |||||||
Salaries, payroll taxes and vacation | $ | 212,247 | $ | 114,030 | ||||
Merchant card fees | 18,946 | 15,062 | ||||||
Professional fees | 58,100 | 25,000 | ||||||
Management incentives | 153,800 | 519,800 | ||||||
Lease liability | 67,660 | 69,402 | ||||||
Dividends – Series F Preferred Stock | 48,389 | |||||||
Inventory in transit | 37,141 | 812,970 | ||||||
Other | 202,638 | 135,837 | ||||||
Totals | $ | 750,532 | $ | 1,740,490 |
10
LogicMark, Inc.
NOTES TO CONDENSED FINANCIAL STATEMENTS
(Unaudited)
NOTE 6 - STOCKHOLDERS’ EQUITY AND REDEEMABLE PREFERRED STOCK
January 2023 Offering
On January 25, 2023, the Company closed a firm commitment registered public offering (the “January Offering”) pursuant to which the Company issued (i) 529,250 shares of Common Stock and 10,585,000 common stock purchase warrants (exercisable for 793,875 shares of Common Stock at a purchase price of $2.52 per share), subject to certain adjustments and (ii) 3,440,000 pre-funded common stock purchase warrants that were exercised for 172,000 shares of Common Stock at a purchase price of $0.02 per share, subject to certain adjustments and 3,440,000 warrants to purchase up to an aggregate of 258,000 shares of Common Stock at a purchase price of $2.52 per share and (iii) 815,198 additional warrants to purchase up to 61,140 shares of Common Stock at a purchase price of $2.52 per share, which additional warrants were issued upon the partial exercise by the underwriters of their over-allotment option, pursuant to an underwriting agreement, dated as of January 23, 2023 between the Company and Maxim Group LLC, as representative of the underwriters. The January Offering resulted in gross proceeds to the Company of approximately $5.2 million, before deducting underwriting discounts and commissions of 7% of the gross proceeds (3.5% of the gross proceeds in the case of certain identified investors) and estimated January Offering expenses. Due to the Company effecting the reverse stock split on April 21, 2023, the exercise prices and shares issuable upon exercise of such warrants and pre-funded warrants have been retroactively reported in accordance with ASC 260-10-55-12, Restatement of EPS Data, and to reflect the adjustment to the number of shares underlying such warrants and pre-funded warrants and the exercise price of such warrants in accordance with the terms thereof. See Note 9.
Series C Redeemable Preferred Stock
In May 2017, the Company authorized Series C Redeemable Preferred Stock. Holders of Series C Preferred Stock are entitled to receive dividends of 15% per year, payable in cash. For each of the three months ended March 31, 2023 and 2022 the Company recorded Series C Redeemable Preferred Stock dividends of $75 thousand.
The Series C Redeemable Preferred Stock may be redeemed by the Company at the Company’s option in cash at any time, in whole or in part, upon payment of the stated value of the Series C Redeemable Preferred Stock and unpaid dividends. If a “fundamental change” occurs, the Series C Redeemable Preferred Stock shall be immediately redeemed in cash equal to the stated value of the Series C Redeemable Preferred Stock, and unpaid dividends. A fundamental change includes but is not limited to any change in the ownership of at least fifty percent of the voting stock; liquidation or dissolution; or the common stock ceases to be listed on the market upon which it currently trades.
The holders of the Series C Redeemable Preferred Stock are entitled to vote on any matter submitted to the stockholders of the Company for a vote. One share of Series C Redeemable Preferred Stock carries the same voting rights as one share of common stock.
A redeemable equity security is to be classified as temporary equity if it is conditionally redeemable upon the occurrence of an event that is not solely within the control of the issuer. Upon the determination that such events are probable, the equity security would be classified as a liability. Given the Series C Redeemable Preferred Stock contains a fundamental change provision, the security is considered conditionally redeemable. Therefore, the Company has classified the Series C Redeemable Preferred Stock as temporary equity in the balance sheets as of March 31, 2023 and December 31, 2022 until such time that events occur that indicate otherwise.
Warrants
The following table summarizes the Company’s warrants outstanding and exercisable as of March 31, 2023 and December 31, 2022:
Number of Warrants |
Weighted Average Exercise Price |
Weighted Average Remaining Life In Years |
Aggregate Intrinsic Value |
|||||||||||||
Outstanding and Exercisable at January 1, 2023 | 4,295,380 | $ | 120.39 | 3.60 | ||||||||||||
Issued | 14,840,198 | 2.52 | 4.82 | |||||||||||||
Issued prefunded warrants | 3,440,000 | 0.02 | ||||||||||||||
Exercised prefunded warrants | (3,440,000 | ) | 0.02 | |||||||||||||
Outstanding and Exercisable at March 31, 2023 | 19,135,578 | $ | 32.78 | 4.49 |
11
LogicMark, Inc.
NOTES TO CONDENSED FINANCIAL STATEMENTS
(Unaudited)
NOTE 7 - STOCK INCENTIVE PLANS
2017 Stock Incentive Plan
On August 24, 2017, the Company’s stockholders approved the 2017 Stock Incentive Plan (“2017 SIP”). The aggregate maximum number of shares of common stock that may be issued under the 2017 SIP is limited to 10% of the outstanding shares of common stock, calculated on the first business day of each fiscal year. Under the 2017 SIP, options which are forfeited or terminated, settled in cash in lieu of shares of common stock, or settled in a manner such that shares are not issued, will again immediately become available to be issued. If shares of common stock are withheld from payment of an award to satisfy tax obligations with respect to the award, those shares of common stock will be treated as shares that have been issued under the 2017 SIP and will not again be available for issuance. On March 7, 2023, at the Special Stockholders’ Meeting, the Company’s 2017 SIP was terminated upon the approval of the 2023 Stock Incentive Plan (“2023 SIP”).
During the three months ended March 31, 2023, the Company issued 3,125 stock options vesting over four years to employees with an exercise price of $3.80 and a total aggregate fair value of $11 thousand. In addition, 10,528 fully vested stock options were granted to four non-employee Board directors at an exercise price of $3.80. The aggregate fair value of the shares issued to the directors was $35 thousand. As of March 31, 2023, the unrecognized compensation cost related to non-vested stock options is $0.4 million.
During the quarter ended March 31, 2022, the Company issued 21,517 shares of common stock vesting over periods ranging from 30 to 48 months with an aggregate fair value of $1.3 million to certain employees as inducement and incentive grants. As of March 31, 2022, the unrecognized compensation cost related to non-vested stock options was $1.1 million.
During the three months ended March 31, 2023, the Company had 625 stock options forfeited under the 2017 SIP.
2013 Long-Term Stock Incentive Plan
On January 4, 2013, the Company’s stockholders approved the Company’s Long-Term Stock Incentive Plan (“LTIP”). The maximum number of shares of common stock that may be issued under the LTIP, including stock awards, stock issued to the Company’s Board, and stock appreciation rights, is limited to 10% of the common shares outstanding on the first business day of any fiscal year. The Company’s LTIP expired in accordance with its terms on January 3, 2023.
During the three months ended March 31, 2023, the Company did not issue any stock options under the LTIP.
During the three months ended March 31, 2022, the Company issued 11,875 stock options vesting over four years to employees with an exercise price of $67.20 and an option for 625 shares with a strike price of $44.00 and a total expense of $0.3 million. In addition, 1,364 fully vested stock options were granted to six non-employee Board directors at an exercise price of $44.00. The aggregate fair value of the shares issued to the directors was $60 thousand, which includes the total expense.
During the three months ended March 31, 2023, the Company had 1,250 stock options forfeited under the LTIP.
Stock-based Compensation Expense
Total stock-based compensation expense during the three months ended March 31, 2023 and 2022 pertaining to awards under the 2017 SIP and 2013 LTIP amounted to $0.4 million and $0.6 million, respectively.
12
LogicMark, Inc.
NOTES TO CONDENSED FINANCIAL STATEMENTS
(Unaudited)
NOTE 8 - COMMITMENTS AND CONTINGENCIES
LEGAL MATTERS
From time to time, the Company may be involved in various claims and legal actions arising in the ordinary course of our business. Other than the above, there is no action, suit, proceeding, inquiry or investigation before or by any court, public board, government agency, self-regulatory organization or body pending or, to the knowledge of the executive officers of the Company or any of our subsidiaries, threatened against or affecting our company, or any of our subsidiaries in which an adverse decision could have a material adverse effect upon our business, operating results, or financial condition.
COMMITMENTS
The Company leases warehouse space and equipment, in the U.S., which is classified as operating leases expiring at various dates. The Company determines if an arrangement qualifies as a lease at the lease inception. Operating lease liabilities are recorded based on the present value of the future lease payments over the lease term, assessed as of the commencement date. The Company’s real estate lease, which is for office space and a fulfillment center, with a lease term of 5 years expiring in August 2025. The Company also leases a copier with a lease term of 5 years, ending August 2023. The Company has elected to account for the lease and non-lease components (insurance and property taxes) as a single lease component for its real estate leases. Lease payments, which includes lease components and non-lease components, are included in the measurement of the Company’s lease liabilities to the extent that such payments are either fixed amounts or variable amounts based on a rate or index (fixed in substance) as stipulated in the lease contract. Any actual costs in excess of such amounts are expensed as incurred as variable lease cost.
The Company’s lease agreements generally do not specify an implicit borrowing rate, and as such, the Company uses its incremental borrowing rate to calculate the present value of the future lease payments. The discount rate represents a risk-adjusted rate on a secured basis and is the rate at which the Company would borrow funds to satisfy the scheduled lease liability payment streams. The Company entered into a new five-year lease agreement in June 2020 for new warehouse space located in Louisville, Kentucky. The Right of Use (ROU) asset value added as a result of this new lease agreement was $0.3 million. The Company’s ROU asset and lease liability accounts reflect the inclusion of this lease in the Company’s balance sheets as of March 31, 2023 and December 31, 2022. The current monthly rent of $6.4 thousand commenced in September 2022 and increases approximately 3% annually thereafter.
The Company’s lease agreements include options for the Company to either renew or early terminate the lease. Renewal options are reviewed at lease commencement to determine if such options are reasonably certain of being exercised, which could impact the lease term. When determining if a renewal option is reasonably certain of being exercised, the Company considers several factors, including significance of leasehold improvements on the property, whether the asset is difficult to replace, or specific characteristics unique to the lease that would make it reasonably certain that the Company would exercise the option. In most cases, the Company has concluded that renewal and early termination options are not reasonably certain of being exercised by the Company and thus not included in the Company’s ROU asset and lease liability.
13
LogicMark, Inc.
NOTES TO CONDENSED FINANCIAL STATEMENTS
(Unaudited)
NOTE 8 - COMMITMENTS AND CONTINGENCIES (CONTINUED)
For the three months ended March 31, 2023, total operating lease cost was $25.4 thousand and is recorded in direct operating costs and general and administrative expenses, dependent on the nature of the leased asset. Operating leases cost for the three months ended March 31, 2022 amounted to $24.6 thousand and was recorded in general and administrative expenses. Operating lease cost is recognized on a straight-line basis over the lease term. The following summarizes (i) the future minimum undiscounted lease payments under the non-cancelable lease for each of the next three years and thereafter, incorporating the practical expedient to account for lease and non-lease components as a single lease component for our existing real estate lease, (ii) a reconciliation of the undiscounted lease payments to the present value of the lease liabilities, and (iii) the lease-related account balances on the Company’s balance sheet as of March 31, 2023:
Year Ending December 31, | ||||
2023 (for the remainder of 2023) | $ | 65,977 | ||
2024 | 80,000 | |||
2025 | 54,400 | |||
Total future minimum lease payments | $ | 200,377 | ||
Less imputed interest | (28,623 | ) | ||
Total present value of future minimum lease payments | $ | 171,754 |
As of March 31, 2023 | ||||
Operating lease right-of-use assets | $ | 164,554 | ||
Accrued expenses | $ | 67,660 | ||
Other long-term liabilities | 104,094 | |||
$ | 171,754 |
As of March 31, 2023 | ||||
Weighted Average Remaining Lease Term | 2.33 | |||
Weighted Average Discount Rate | 12.95 | % |
NOTE 9 – SUBSEQUENT EVENTS
The Company’s management has evaluated subsequent events through May 12, 2023, which is the date these condensed financial statements were available to be issued. Except as discussed below, management has determined that there were no subsequent events which required recognition, adjustment to or disclosure to the condensed financial statements:
Reverse Stock Split
On April 21, 2023, the Company effected a 1-for-20 reverse split of its outstanding common stock and Series C Redeemable Preferred Stock. As a result of the reverse splits, each 20 pre-split shares of common stock outstanding and each 20 pre-split shares of Series C Redeemable Preferred Stock outstanding were automatically exchanged for one new share of each without any action on the part of the holders. The number of outstanding shares of common stock was reduced from approximately 24,406,155 shares to approximately 1,220,308 shares, and the number of outstanding shares of Series C Redeemable Preferred Stock was reduced from 200 shares to 10 shares. No fractional shares were issued as a result of the reverse stock split, all of which were rounded up to the nearest whole number. The reverse stock splits did not affect the total number of shares of capital stock, including Series C Redeemable Preferred Stock, that the Company is authorized to issue.
Net loss per share and all share data as of and for the three months ended March 31, 2023 and 2022 have been retroactively adjusted to reflect the reverse stock splits that occurred on April 21, 2023 in accordance with ASC 260-10-55-12, Restatement of EPS Data.
14
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
The following discussion and analysis of our financial condition and results of operations for the three months ended March 31, 2023, should be read together with our condensed financial statements and related notes included elsewhere in this Quarterly Report on Form 10-Q for the three months ended March 31, 2023 (this “Form 10-Q”). This discussion contains forward-looking statements and information relating to our business that reflect our current views and assumptions concerning future events and is subject to risks and uncertainties that may cause our or our industry’s actual results, levels of activity, performance, or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. These forward-looking statements speak only as of the date of this Form 10-Q. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, levels of activity, or achievements. Except as required by applicable law, including the securities laws of the United States, we expressly disclaim any obligation or undertaking to disseminate any update or revisions of any of the forward-looking statements to reflect any change in our expectations with regard thereto or to conform to these statements to actual results.
Overview
LogicMark, Inc. provides PERS, health communications devices, and Internet of Things (“IoT”) technology that creates a connected care platform. The Company’s devices provide people with the ability to receive care at home and age independently and to check, manage and monitor a loved one’s health and safety remotely. The Company’s PERS devices incorporate two-way voice communication technology directly in the medical alert pendant and providing life-saving technology at a consumer-friendly price point aimed at everyday consumers. The Company is focused on modernizing remote monitoring to help people stay safe and live independently longer. The PERS technologies are sold through retailers and distributors, the Company’s website (logicmark.com) as well as through the United States Veterans Health Administration (“VHA”). The Company enjoys a strong base of business with the VHA and plans to expand to other government services after being awarded the five-year United States General Services Agreement (“GSA”) in 2021.
Recent Developments
Resignation of Director
On April 1, 2023, Sherice R. Torres notified the board of directors of her resignation from the Board, effective April 7, 2023. The resignation of Ms. Torres as a director was not related to any disagreement with the Company on any matter relating to the Company’s operations, policies or practices. Ms. Torres was also a member of the Board’s corporate governance and nomination committee and the Chair of the Board’s compensation committee.
Reverse Stock Split
On April 21, 2023, the Company executed a 1-for-20 reverse stock-split of the Company’s outstanding shares of Common Stock and Series C Redeemable Preferred Stock (collectively, the “Reverse Stock Split”), whereby every 20 shares of Common Stock and Series C Redeemable Preferred Stock was consolidated into 1 share of each such class following the Reverse Stock Split, with fractional shares rounded up to the nearest whole share.
Results of Operations
Three months ended March 31, 2023, compared with the three months ended March 31, 2022.
Revenue, Cost of Goods Sold, and Gross Profit
Three Months Ended | ||||||||||||||||
March 31, | ||||||||||||||||
2023 | 2022 | $ Change | % Change | |||||||||||||
Revenue | $ | 2,809,717 | $ | 3,650,689 | $ | (840,972 | ) | -23 | % | |||||||
Cost of Goods Sold | 947,169 | 1,447,305 | (500,136 | ) | -35 | % | ||||||||||
Gross Profit | $ | 1,862,548 | $ | 2,203,384 | $ | (1,341,108 | ) | |||||||||
Profit Margin | 66 | % | 60 | % |
We experienced a 23% decrease in revenue for the three months ended March 31, 2023, as compared to the three months ended March 31, 2022. Results in the prior year period included one-time sales of 4G units replacing 3G units no longer supported by national cellular network carriers.
Gross profit margin for the three months ended March 31, 2023, was 66%, up from 60% in the three months ended March 31, 2022, as a result of improvements in the Company’s supply chain management, including a return to transpacific shipping (versus air freight) from our Asia based contract manufacturers.
15
Operating Expenses
Three Months Ended | ||||||||||||||||
March 31, | ||||||||||||||||
Operating Expenses | 2023 | 2022 | $ Change | % Change | ||||||||||||
Direct operating cost | $ | 262,800 | $ | 474,442 | $ | (211,642 | ) | -45 | % | |||||||
Advertising costs | 48,116 | - | 48,116 | 100 | % | |||||||||||
Selling and marketing | 465,536 | 189,207 | 276,329 | 146 | % | |||||||||||
Research and development | 313,887 | 262,484 | 51,403 | 20 | % | |||||||||||
General and administrative | 2,413,760 | 2,335,949 | 77,811 | 3 | % | |||||||||||
Other expense | 28,318 | 30,084 | (1,766 | ) | -6 | % | ||||||||||
Depreciation and amortization | 215,998 | 194,363 | 21,635 | 11 | % | |||||||||||
Total Expenses | $ | 3,748,415 | $ | 3,486,529 | $ | 261,886 |
Direct Operating Cost
The $0.2 million decrease in direct operating cost for the three months ended March 31, 2023 compared to March 31, 2022, was primarily driven by a reduction in warranty claims related to the sunsetting of 3G cellular support by the national cellular network carriers. In the three months ended March 31, 2022, while we were not obligated to upgrade our customers with 3G PERS units to 4G compatible units, we chose to replace those units still under warranty and to cover all such replacement costs.
Advertising Costs
The $48.1 thousand increase in advertising costs for the three months ended March 31, 2023, compared to March 31, 2022, was driven by the initiation of social media advertising and web-based advertising to support our eCommerce platform.
Selling and Marketing
The $0.3 million increase in selling and marketing expenses for the three months ended March 31, 2023, was driven by the three-month impact in 2023 of marketing service firms added in late 2022 to support such areas as public relations, investor relations and the additional sales personnel and their related expenses.
Research and Development
The Company entered calendar year 2022 with no new products in the product pipeline and has been working diligently on developing new PERS hardware and other software-based solutions for our customers. As a result, our research and development expense for the three months ended March 31, 2023, compared to March 31, 2022, increased as we ramp up these development efforts.
General and Administrative
General and administrative costs increased $0.1 million for the three months ended March 31, 2023, compared to the March 31, 2022 period, which was driven by higher recruiting costs and costs related to the March 7, 2023 Special Meeting of Stockholders.
Other Income
Three Months Ended | ||||||||||||||||
March 31, | ||||||||||||||||
Other Income | 2023 | 2022 | $ Change | % Change | ||||||||||||
Interest income | $ | 52,428 | $ | - | $ | 52,428 | 100 | % | ||||||||
Total Other Income | $ | 52,428 | $ | - | $ | 52,428 | 100 | % |
During the three months ended March 31, 2023, the Company recorded $52.4 thousand of interest income generated from its cash balances. There was no interest income or interest expense recorded during the three months ended March 31, 2022 as the banking institution did not pay interest on excess balances.
16
Liquidity and Capital Resources
Sources of Liquidity
The Company generated an operating loss of $1.9 million and a net loss of $1.8 million for the three months ended March 31, 2023. As of March 31, 2023, the Company had cash and cash equivalents of $9.8 million. At March 31, 2023, the Company had working capital of $10.0 million. During the three months ended March 31, 2023, the Company received proceeds of $5.2 million from the issuance of Common Stock, warrants, and the exercise of Common Stock purchase warrants.
Given our cash position as of March 31, 2023 and our projected cash flow from operations, we believe we will have sufficient capital to sustain operations for the twelve months from the filing of these condensed financial statements. We may raise funds through equity or debt offerings to accelerate the execution of our long-term strategic plan to develop and commercialize our new products.
Cash Flows
Cash (Used in) Provided by Operating Activities
During the three months ended March 31, 2023, net cash used in operating activities was $1.4 million. During the three months ended March 31, 2022, net cash provided by operating activities was $0.3 million. Our primary ongoing uses of operating cash relate to payments to vendors, salaries and related expenses for our employees and consulting and professional fees. Our vendors and consultants generally provide us with normal trade payment terms (net 30).
Cash Used in Investing Activities
During the three months ended March 31, 2023, we invested $0.3 million in equipment and product development. During the three months ended March 31, 2022, we purchased $37 thousand in equipment.
Cash Provided by (Used) Financing Activities
Three Months Ended | ||||||||
Cash flows from Financing Activities | 2023 | 2022 | ||||||
Proceeds from sale of common stock and warrants | $ | 5,211,428 | $ | - | ||||
Fees paid in connection with equity offerings | (805,245 | ) | - | |||||
Series C redeemable preferred stock dividends | (75,000 | ) | (75,000 | ) | ||||
Net Cash Provided by (Used in) Financing Activities | $ | 4,331,183 | $ | (75,000 | ) |
During the three months ended March 31, 2023, we completed a registered public offering of common stock and warrants, whereby we received proceeds of $5.2 million and paid fees of $0.8 million. During the three months ended March 31, 2023 and 2022, we paid Series C Redeemable Preferred Stock dividends amounting to $75 thousand each period.
Impact of Inflation
We believe that our business has not been affected to a material degree by inflationary trends during the past two fiscal years. However, continued domestic inflation may increase our cost of fulfilment in fiscal year 2023 through higher labor and shipping costs, as well as our operating and overhead expenses. Should inflation become a continuing factor in the worldwide economy, it may increase the cost of purchasing products from our contract manufacturers in Asia, as well as the cost of certain raw materials, component parts and labor used in the production of our products. We have generally been able to maintain our profit margins through productivity, better supply chain management, efficiency improvements, and cost reduction programs.
Off-Balance Sheet Arrangements
We do not have any relationships with unconsolidated entities or financial partnerships, such as entities often referred to as structured finance or special purpose entities, which would have been established to facilitate off-balance sheet arrangements or other contractually narrow or limited purposes. In addition, we do not have any undisclosed borrowings or debt, and we have not entered into any synthetic leases. We are, therefore, not materially exposed to any financing, liquidity, market, or credit risk that could arise if we had engaged in such relationships.
Critical Accounting Policies
There were no significant changes to our critical accounting policies and estimates during the three months ended March 31, 2023, from those disclosed in our Annual Report on Form 10-K for the year ended December 31, 2022.
17
Item 3. Quantitative and Qualitative Disclosures about Market Risk.
We are not required to provide the information required by this Item as we are a smaller reporting company.
Item 4. Controls and Procedures
Evaluation of Disclosure Controls and Procedures
Under the supervision and with the participation of our management, including our principal executive officer and principal financial officer, we are required to perform an evaluation of our disclosure controls and procedures, as such term is defined in Rule 13a-15(e) under the Exchange Act, as of March 31, 2023. Management has not completed such evaluation under the 2013 Committee of Sponsoring Organizations (“COSO”) framework, but concluded, based on the material weaknesses in our internal controls over financial reporting described below, that our disclosure controls and procedures were not effective as of March 31, 2023 to provide reasonable assurance that information required to be disclosed by us in reports we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms, and is accumulated and communicated to our management, including our principal executive officer and principal financial officer, as appropriate to allow timely decisions regarding required disclosures. Specifically, we had difficulty in accounting for complex accounting transactions due to an insufficient number of accounting personnel with experience in that area and limited segregation of duties within our accounting and financial reporting functions.
As reported in our Annual Report on Form 10-K for the period ended December 31, 2022, the Company retained a Corporate Controller, a Certified Public Accountant in the state of California, with over 10 years of public accounting, audit and accounting experience to assist in completing our remediation procedures for the material weaknesses identified regarding the following:
- | Management had not completed an assessment of the Company’s internal controls over financial reporting based on the 2013 COSO framework. Management has concluded that, during the first three months of 2023, its internal controls and procedures were not effective to detect the inappropriate application of U.S. GAAP. | |
- | Due to a limited number of accounting personnel, the Company has historically had difficulty accounting for complex transactions and has limited segregation of duties within the accounting department. |
Additional time is required to fully document our systems, implement control procedures, and test their operating effectiveness before we can conclude that we have fully remediated our material weaknesses.
Changes in Internal Control over Financial Reporting
There were no changes in the Company’s internal control over financial reporting that occurred during the three months ended March 31, 2023, that have materially affected or are reasonably likely to materially affect our internal control over financial reporting.
Limitations of the Effectiveness of Internal Control
Our management, including our Chief Executive Officer and Chief Financial Officer, does not expect that our disclosure controls and procedures will prevent all errors and all fraud. A control system, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. Further, the design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their costs. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, have been detected. These inherent limitations include, but are not limited to, the realities that judgments in decision making can be faulty and that breakdowns can occur because of simple errors. Additionally, controls can be circumvented by the individual acts of some persons, by collusion of two or more people, or by management override of the control. The design of any system of controls is also based in part upon certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions. Because of the inherent limitations in a cost-effective control system, misstatements due to error or fraud may occur and not be detected.
18
Part II. OTHER INFORMATION
Item 1. Legal Proceedings
From time to time, we may become subject to legal proceedings, claims, or litigation arising in the ordinary course of business. We are not presently a party to any other legal proceedings that in the opinion of our management, if determined adversely to us, would individually or taken together have a material adverse effect on our business, operating results, financial condition, or cash flows.
Item 1A. Risk Factors
As a smaller reporting company, we are not required to provide the information required by this item.
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
Not applicable.
Item 3. Defaults Upon Senior Securities
None.
Item 4. Mine Safety Disclosures
Not applicable.
Item 5. Other Information
None.
Item 6. Exhibits
Exhibit | ||
Number | Description | |
31.1* | Certification of Principal Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 | |
31.2* | Certification of Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 | |
32.1 | Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 | |
32.2 | Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 | |
101.INS | Inline XBRL Instance Document | |
101.SCH | Inline XBRL Taxonomy Extension Schema Document | |
101.CAL | Inline XBRL Taxonomy Extension Calculation Linkbase Document | |
101.DEF | Inline XBRL Taxonomy Extension Definition Linkbase Document | |
101.LAB | Inline XBRL Taxonomy Extension Label Linkbase Document | |
101.PRE | Inline XBRL Taxonomy Extension Presentation Linkbase Document | |
104 | Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101) |
In accordance with SEC Release 33-8238, Exhibits 32.1 and 32.2 are being furnished and not filed.
* | Filed herewith. |
19
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this Report to be signed on its behalf by the undersigned, thereunto duly authorized.
LogicMark, Inc. | ||
Date: May 12, 2023 | By: | /s/ Chia-Lin Simmons |
Chia-Lin Simmons | ||
Chief Executive Officer | ||
(Principal Executive Officer) | ||
Date: May 12, 2023 | By: | /s/ Mark Archer |
Mark Archer | ||
Chief Financial Officer | ||
(Principal Financial Officer and Principal Accounting Officer) |
20